• Poster

Impact of Lapatinib Plus Trastuzumab Versus Single-Agent Lapatinib on Quality of Life of Patients With Trastuzumab-Refractory HER2+ (ErbB2+) Metastatic Breast Cancer

Citation

Burstein, H., Blackwell, K. M., Wu, Y., Storniolo, A., Rugo, H., Amonkar, M., ... O'Shaughnessy, J. (2008, September). Impact of Lapatinib Plus Trastuzumab Versus Single-Agent Lapatinib on Quality of Life of Patients With Trastuzumab-Refractory HER2+ (ErbB2+) Metastatic Breast Cancer. Presented at 2008 ASCO Breast Cancer Symposium, .

Abstract